SPOTLIGHT -
Oncology Drug Exkivity to be Voluntarily Withdrawn From US Market
Exkivity remains available while Takeda works with the FDA on withdrawal timing, and the company said that patients currently taking the therapy will continue to have access after it is withdrawn.
Many Feel US Health Care Puts Profit Over Patients
The fight to put the consumer first in health care remains as many Americans feel the industry is still putting the mighty dollar ahead of patients.
At-Home COVID-19 Tests: Gaps Reported in Usability
As the need for rapid tests increase, the nation's largest non-profit patient safety organization evaluated seven COVID-19 rapid tests and found serious gaps in their usability.
Long-term Preparedness Needed for Future Healthcare Crises, Study Shows
New study shows opportunity exists to make healthcare more durable to further long-term gains in preparedness for emergencies like COVID-19.
